IGF1 and Alzheimer disease: In addition, the level of Aβ42 was increased by miR-98 overexpression in the cell lysates of AD cell culture model (N2a/APP) while IGF-1 supplementation rescued the Aβ42 accumulation, suggesting that miR-98 is involved in AD pathogenesis by negatively regulating IGF-1.